Literature DB >> 12810482

Getting the spinal cord to think for itself.

Robert G Kalb1.   

Abstract

Despite the interruption in communication between the brain and lower centers by spinal cord injury, many of the neurons engaged in generating locomotion survive. Several strategies have been used to activate spinal cord circuitry independent of the higher centers, including direct electrical stimulation, pharmacological agents, and training programs that involve moving the legs through the motions of walking. Ambulatory leg movements are achieved by these interventions, leading to substantial functional improvements in the subset of patients with incomplete spinal cord injury. The neurobiological basis for these phenomena likely involves activity-dependent reconfiguration of synaptic connections within the spinal cord. Fostering this process may lead to further benefits for individuals with spinal cord injury.

Entities:  

Keywords:  Non-programmatic

Mesh:

Year:  2003        PMID: 12810482     DOI: 10.1001/archneur.60.6.805

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  3 in total

1.  Role of GluR1 in activity-dependent motor system development.

Authors:  Lei Zhang; Joachim Schessl; Markus Werner; Carsten Bonnemann; Guoxiang Xiong; Jelena Mojsilovic-Petrovic; Weiguo Zhou; Akiva Cohen; Peter Seeburg; Hidemi Misawa; Aditi Jayaram; Kirkwood Personius; Michael Hollmann; Rolf Sprengel; Robert Kalb
Journal:  J Neurosci       Date:  2008-10-01       Impact factor: 6.167

2.  Brain motor system function in a patient with complete spinal cord injury following extensive brain-computer interface training.

Authors:  Christian Enzinger; Stefan Ropele; Franz Fazekas; Marisa Loitfelder; Faton Gorani; Thomas Seifert; Gudrun Reiter; Christa Neuper; Gert Pfurtscheller; Gernot Müller-Putz
Journal:  Exp Brain Res       Date:  2008-07-01       Impact factor: 1.972

3.  The molecular basis of experience-dependent motor system development.

Authors:  Robert G Kalb; Weiguo Zhou; Lei Zhang
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.